|
Benefit from letrozole as extended adjuvant therapy after sequential endocrine therapy: A randomized, phase III study of Gruppo Italiano Mammella (GIM). |
|
|
Honoraria - Eisai; Ipsen; Lilly; Novartis; Pfizer; Roche; Takeda |
Consulting or Advisory Role - Lilly; MSD; Roche |
Travel, Accommodations, Expenses - Pfizer; Roche |
|
|
Consulting or Advisory Role - Celgene; Novartis; Pfizer |
Travel, Accommodations, Expenses - AstraZeneca; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novartis; Roche |
Speakers' Bureau - AstraZeneca; Novartis; Pfizer |
Travel, Accommodations, Expenses - Celgene; Lilly; Pfizer; Roche |
|
|
Consulting or Advisory Role - Eisai; Istituto Gentili |
Travel, Accommodations, Expenses - Celgene; Eisai; Istituto Gentili |
|
|
No Relationships to Disclose |
|
|
Employment - Novartis (I) |
Consulting or Advisory Role - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis; Pfizer; Roche; Teva |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca (I); Celgene; GlaxoSmithKline; Ipsen; Lilly; Novartis; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Celgene; GlaxoSmithKline; Ipsen; Lilly; Novartis; Pfizer; Roche |
Research Funding - AstraZeneca; Eisai; Novartis; Roche |
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche |
|
|
Honoraria - Celgene; Eisai; Novartis; Pfizer |
Consulting or Advisory Role - Amgen; Celgene; Eisai; Pfizer |
Research Funding - Eisai (Inst); Eisai (Inst) |
Travel, Accommodations, Expenses - Celgene; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Teva |
|
|
No Relationships to Disclose |